- Recommendation ID
- NG230/02
- Question
Duration of follow up: What is the clinical and cost effectiveness for different durations of follow up for people with differentiated thyroid cancer who have been treated?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on follow up.
Full details of the evidence and the committee's discussion are in evidence review Q: length and frequency of follow up.
Source guidance details
- Comes from guidance
- Thyroid cancer: assessment and management
- Number
- NG230
- Date issued
- December 2022
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/12/2022 |